PK/PD of topically administered ophthalmic IOP drug formulations in rabbit
Ended Awarded Last action
- Contract number
- 75F40120F19002
- Awardee
-
Pharmaron (San Diego) Lab Services LLC UEI MMXQBTUNPEH3 Part of Pharmaron (Exton) Lab Services LLC
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,574,070
Award facts
- Contract value 100% obligated
- $1,574,070.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92111, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $867,475 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $706,595 |
About this award
The Food and Drug Administration (FDA) awarded a $1.57M firm fixed price delivery order to Pharmaron (San Diego) Lab Services LLC for pharmacokinetic and pharmacodynamic (PK/PD) studies of topically administered ophthalmic intraocular pressure drug formulations in rabbits. The contract, which was modified to extend performance through September 28, 2022, represents work to be performed in San Diego, California. This delivery order was issued without a set-aside designation and supports the FDA's drug evaluation and regulatory mission by generating preclinical data necessary to assess the safety and efficacy of ophthalmic pharmaceutical candidates.
Pharmaron (San Diego) Lab Services LLC, a division of Pharmaron (Exton) Lab Services LLC (doing business as Absorption Systems), is a global contract research organization specializing in pharmaceutical research and development services. The company has established itself as a key federal contractor for the FDA and National Institutes of Health, providing specialized testing services including pharmacokinetic analysis, drug metabolism studies, and analytical assessments that directly support the regulatory evaluation of pharmaceutical products. This award exemplifies the company's core competency in conducting in-vivo preclinical studies required for ophthalmologic drug development and regulatory submission.
Quick answers
Who was awarded contract 75F40120F19002?
75F40120F19002 was awarded to Pharmaron (San Diego) Lab Services LLC by Food and Drug Administration (Department of Health and Human Services) on September 29, 2020.
How much is contract 75F40120F19002 worth?
The government has obligated $1,574,070 on 75F40120F19002.
Is contract 75F40120F19002 an order under another contract?
Yes. 75F40120F19002 is a delivery order under 75F40119D10024, an indefinite delivery contract.
Was contract 75F40120F19002 competed?
The extent of competition for 75F40120F19002 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award